The microenvironment is increasingly recognized to have key roles in cancer, and
biomaterials provide a means to engineer microenvironments both in vitro and in vivo to …

Advances in immunotherapy have led to the development of a variety of promising
therapeutics, including small molecules, proteins and peptides, monoclonal antibodies, and …

Highlights•Biomaterials can potentially improve the safety and efficacy of cancer
immunotherapy.•Biomaterials scaffolds can program immune cell function in peripheral …

The field of drug delivery has grown tremendously in the past few decades by developing a
wide range of advanced drug delivery systems. An interesting category is cell-based drug …

Immunotherapies for cancer have progressed enormously over the past few decades, and
hold great promise for the future. The successes of these therapies, with some patients …

A major demand on immunotherapy is the direct interference with specific immune cells in
vivo. In contrast to antibody-engineered nanoparticles to control dendritic cells function …

Founded on the growing insight into the complex cancer-immune system interactions,
adjuvant immunotherapies are rapidly emerging and being adapted for the treatment of …